Genzyme Boosts Offer for Anormed, Topping Millennium (Update2) Bloomberg - By Catherine Larkin. Oct. 10 (Bloomberg) - - Genzyme Corp. increased its offer to buy Anormed Inc. to $580 million in cash, topping Millennium Pharmaceuticals Inc.

Landscaping, Painting and Even More Serious Sprucing May Be More Necessary in the Cooler Real Estate Market

SINGAPORE (Reuters) - Oil stood above $60 on Tuesday after forecasts of a cold spell in the U.S. Northeast buoyed heating oil, and as a weaker dollar and a Saudi warning of possible new output curbs bolstered the market.